Who Paid My Doc
Embozene
Device Embolics
General payments
$38,952
Research payments
$116,966
Through program year 2020, $38,952 in general payments and $116,966 in research payments were reported against Embozene (Embolics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $1,352 | 17 |
| 2020 | Research | $16,500 | 1 |
| 2019 | General | $37,600 | 273 |
| 2019 | Research | $100,466 | 3 |
Breakdown
The top 5 of 12 recipients; each share is of general payments naming this product in 2020.
Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2020 where a state was reported.
Records
290 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.